CAM
DARE icon

Cormorant Asset Management’s Dare Bioscience DARE Stock Holding History

Cormorant Asset Management’s Portfolio DARE Stock Details DARE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-4,595
Closed -$2.02M – 85
2015
Q3 		$2.02M Hold
4,595
– – 0.32% 61
2015
Q2 		$2.54M Buy
4,595
+1,250
+37% +$858K 0.34% 58
2015
Q1 		$3.62M Sell
3,345
-405
-11% -$392K 0.56% 49
2014
Q4 		$2.8M Hold
3,750
– – 0.43% 50
2014
Q3 		$1.9M Hold
3,750
– – 0.39% 53
2014
Q2 		$2.61M Buy
+3,750
New +$2.89M 0.69% 46

Other funds holding DARE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PVMCV
Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return
PVMCI
Polaris Venture Management Co IV Boston, Massachusetts $62.4M AUM 33.04% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return

Cormorant Asset Management's DARE Position: Q4 2015 in Review

Cormorant Asset Management sold out of Dare Bioscience (DARE) in Q4 2015, closing a stake of 4,595 shares — an estimated $2.02M sold.

Cormorant Asset Management first reported a position in DARE in Q2 2014 and held it in 6 quarters. The position peaked at $3.62M in Q1 2015. 37 funds tracked by Wall St. Rank hold DARE as of Q4 2015.

  • Cormorant Asset Management reported no remaining Dare Bioscience position as of Q4 2015 after selling out during the quarter.
  • Cormorant Asset Management sold 4,595 Dare Bioscience shares in Q4 2015, an estimated $2.02M.
  • Cormorant Asset Management first reported a position in Dare Bioscience in Q2 2014 and held it in 6 quarters.
  • Cormorant Asset Management's Dare Bioscience position peaked at $3.62M in Q1 2015.
  • 37 funds tracked by Wall St. Rank held Dare Bioscience as of Q4 2015.

Based on Cormorant Asset Management's 13F filing for Q4 2015, filed 16 Feb 2016.